RDHL · RedHill Biopharma Ltd.

$0.60 +0.00 (+0.82%) At close · Aug 14

Market Cap

$3.65M

6.08M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-07-28	Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
2026-06-22	RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
2026-06-18	RedHill Biopharma Announces Up To $19.4 Million Private Placement
2026-06-09	RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
2026-06-08	RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
2026-06-02	RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
2026-04-30	RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
2026-04-27	RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
2026-04-22	RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
2026-02-25	Joint U.S. Commercialization of RedHill's Talicia® Commences
2026-01-05	RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
2025-12-15	RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

Past events

Date	Event	Type
2026-08-06	Annual General Meeting of Shareholders	Shareholder meeting
2026-06-22	BIO International Convention 2026	Event
2026-03-23	BIO-Europe Spring	Event
2026-03-05	Extraordinary General Meeting of Shareholders	Shareholder meeting
2026-03-02	BIO Investment and Growth Summit	Event
2025-11-03	BIO-EUROPE, 3 - 5th November, Vienna, Austria	Event
2025-10-08	Sachs 25th Annual Biotech in Europe Forum	Event
2025-06-16	BIO International Convention 2025	Event
2025-05-05	2025 Annual General Meeting of Shareholders	Shareholder meeting
2025-02-26	18th Annual European Life Sciences CEO Forum (Sachs_ELSF)	Event
2024-06-03	BIO International Convention 2024	Event
2024-05-31	ASCO Annual Meeting 2024	Shareholder meeting
2024-05-08	Aegis Capital Virtual Conference	Conference
2022-11-21	2nd International Conference on Microbiology & Infectious Diseases	Conference
2022-10-21	American College of Gastroenterology Annual Meeting (ACG)	Shareholder meeting
2022-09-12	H.C. Wainwright 24th Annual Global Investment Conference	Conference
2022-08-17	World Gastro 2022	Event
2022-08-07	International Conference on Emerging Infectious Diseases (ICEID)	Conference
2022-07-13	2nd ARDS Drug Development Summit	Event
2022-06-23	First Quarter 2022 Financial Results & Operational Highlights Webcast	Earnings call
2022-05-24	H.C. Wainwright Global Investment Conference	Conference
2022-05-13	RedHill Biopharma Annual General Meeting of Shareholders	Shareholder meeting
2022-03-29	2022 Cantor Virtual Rare Orphan Disease Summit	Event
2022-03-28	BIO-Europe Spring 2022 Digital Conference	Conference
2022-03-17	Q4 & Full Year 2021 Financial Results Conference Call & Webcast	Earnings call

Source: https://www.redhillbio.com/investors/overview/default.aspx

Key facts CIK 1553846 CUSIP 757468301 13F (30d) 13 filings 13 filers Visit website Investor relations